State Of New Jersey Common Pension Fund D Uni Qure N.V. Transaction History

State Of New Jersey Common Pension Fund D

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$29.24 - $42.03 $1.67 Million - $2.39 Million	-56,973 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$35.35 - $50.67 $59,706 - $85,581	-1,689 Reduced 2.88%	56,973 $2.06 Million
Q3 2020 Oct 27, 2020	BUY	$35.98 - $47.66 $933,465 - $1.24 Million	25,944 Added 79.3%	58,662 $2.16 Million
Q2 2020 Aug 04, 2020	SELL	$45.06 - $67.74 $365,842 - $549,981	-8,119 Reduced 19.88%	32,718 $1.47 Million
Q4 2019 Jan 31, 2020	BUY	$37.13 - $74.62 $302,126 - $607,182	8,137 Added 24.88%	40,837 $2.93 Million
Q3 2019 Oct 23, 2019	BUY	$39.36 - $76.8 $1.29 Million - $2.51 Million	32,700 New	32,700 $1.29 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.